Our Latest Science Jobs in the UK

Here is a list of the latest science jobs we have had in this week. Click on the links below to find out more and be the first to apply!

Rubber Chemist/ Rubber Technologist – South Wales

Microbiologist – Pharmaceutical, NE England

Test Rig Operator – Catalyst, Chemical, Oxford

Catalyst Coating Specialist – Oxfordshire

Formulation Scientist – Agrochemicals, West Mids

Process Technologist – County Durham

Sales Engineer – Oil & Gas, Waste Water, Essex

Quality Assurance Representative – North West

Product Development ScientistCentral Belt of Scotland

Stability Team Leader – PharmaceuticalNorth East

QA Manufacturing Support Engineer – Yorkshire

Production Operative – Herts

Shift Process Chemist – Oxfordshire

Regulatory Manager – East Anglia

Senior Chemist – UV Coatings, Greater London

Head of ProductionNorthern Ireland

Senior Chemist – Packaging, FMCG, Hertfordshire

Analytical Scientist – Herts

Shift Chemist – Teeside

Compliance OfficerNE England

Medical Devices Sterile SpecialistEast Midlands

Shift Chemist – Teeside

Microbiology AnalystTeeside

Not quite what you’re looking for? Click here to register your CV with us today.

Follow us on Twitter @CKScienceJobs to receive more industry news and CK jobs of the week updates

Posted in Industry News, Jobs, NewsTagged in , , , , , , , , , , , , , , , , , ,

BioCity Scotland Announces BioEntrepreneur Boot Camp

BioCity Nottingham news reported that BioCity Scotland announced its first Bio Entrepreneur Boot Camp. This will be a three-day intensive business development program designed to prepare scientists to be their own boss.

The program is designed for anyone thinking of starting a life sciences company or in the early stage of company development. It will be delivered by business professionals, many of whom have run their own firms or advise small companies. Delegates will work on practical exercises and case studies; enjoy lively discussion and networking, and will benefit from one-to-one mentoring. Topics to be covered include market research, financial planning, business law, intellectual property, leadership and promotion. The individual sessions build towards a friendly ‘Dragons Den’ style competitive pitch to a panel of industry experts on the final day.

The course will take place over 3 days from Wednesday 25th to Friday 27th April, and is sponsored by North Lanarkshire Council.

Click here to see our life science jobs

Follow us on Twitter @CKScienceJobs to receive more industry news and CK jobs of the week updates

Posted in Industry News, NewsTagged in , , , , , , , , , ,

Eli Lilly gives $100,000 to American Red Cross Tornado Disaster Relief Efforts

As reported by Pharmiweb, The Eli Lilly and Company Foundation yesterday gave $100,000 to the American Red Cross for its tornado disaster relief efforts.

This pledge will support families and communities affected by the tornadoes that blazed through Indiana, Kentucky, Ohio, Alabama, and Georgia on March 2, 2012.

Robert L. Smith, president of the Lilly Foundation said “Our hearts go out to those affected by these tornadoes, including those in our home state of Indiana. We’ve been moved by the acts of kindness by people who have sought to help those in need. Today, we join the ranks of many others in answering the call to help”

In addition to this pledge, through its matching gifts program, the Lilly Foundation will provide a 1:1 match of employee donations to the American Red Cross and the Salvation Army.  The Foundation is encouraging U.S. Lilly employees who want to donate to tornado relief efforts to do so through one of these organizations, thereby doubling the impact of their giving.

Click here to see our current pharmaceutical jobs now

Follow us on Twitter @CKScienceJobs to receive more industry news and CK jobs of the week updates

Posted in Industry News, NewsTagged in , , , , , , ,

Meet Naynesh Mistry – Permanent Recruitment Consultant in the Midlands

Naynesh Mistry has been with CK Science since August 2012 and is based in the Chesterfield office. He is responsible for permanent scientific recruitment in the following industries in the Midlands area:

  • Pharmaceutical
  • Biotechnology
  • Food
  • Life Sciences
  • Medical Devices

To find out more watch his short video below:


You can contact Naynesh Mistry on 0114 283 9956 or email nmistry@ckscience.co.uk.

To meet the rest of the CK Science team, please click here

Posted in Industry News, NewsTagged in , , , , , , , ,

Boehringer Ingelheim provide free first aid training for Berkshire children

Boehringer Ingelheim released a statement earlier this year stating that the Bracknell based pharmaceutical company is teaming up with St Johns Ambulance and Bracknell News to provide free first aid training in Berkshire schools.

Boehringer Ingelheim is sponsoring a part time St Johns Ambulance liaison officer to provide free first aid training in schools. Natasha Bright will be available to the schools at little or no cost to carry out training, before schools had to pay for training, so the initiative will save them hundreds of pounds or mean more taking advantage of first aid training.

Boehringer Ingelheim’s involvement in free first aid training started in 2009 when, in liaison with the Bracknell News and St John, it launched free Childlifesaver courses for readers to learn basic skills required to save a baby or toddler’s life.

Duncan Cantor, director of communications at Boehringer, said: “As a company, we are committed to family health. This year is the 50th anniversary of the opening our UK office and what better way to celebrate our half-century in Bracknell than by extending the work we have already done in the first aid arena to local children. By helping them to learn the basic first aid skills they may, one day, be in a position to save someone’s life and that, for me, is a pretty good legacy for any company to have.”

Click here to search our pharma jobs

Follow us on Twitter @CKScienceJobs to receive more industry news and CK jobs of the week updates

Posted in Industry News, NewsTagged in , , , , , , , , , , , , , , , ,

Abbott to invest €85m at its pharmaceutical site

Abbott Ireland released plans to invest €85 million at its pharmaceutical manufacturing operation in Sligo, Ireland.  This investment will result in the creation of up to approximately 175 highly skilled jobs, these new roles will include  engineering, quality, pharmaceutical science and other science-based areas.

The majority of the jobs will be added during the construction phase and the remainder will come on stream post the completion of the expansion. In addition, construction employment will create up to 150 temporary jobs. The expansion of the facility will be completed in 2014. The investment is supported by the Irish Government through IDA Ireland.

Dr. Azita Saleki-Gerhardt, President, Global Pharmaceutical Operations, Abbott said  “Abbott has had a presence in Ireland for more than 65 years and began manufacturing in the country in 1974. Sligo is an important part of Abbott’s pharmaceutical manufacturing network and we are pleased to expand it to support future production needs. The success of our Sligo facility is due to the dedication of its staff and management. This state-of-the-art expansion will enable us to produce innovative therapies that we expect will represent significant advances in the treatment of cancer, chronic kidney disease and viral infections,”

Click here to search our jobs in science now

Posted in Industry News, NewsTagged in , , , , , , , , , ,

A new state-of-the art microscope will revolutionise the detection of cancer in Scotland

The Scotsman.com has reported that a NEW state-of-the art microscope is currently under construction at the Edinburgh Cancer Research UK Centre at the city’s Western General Hospital. This new microscope will revolutionise the detection and treatment of cancer in Scotland by giving scientists the ability to track rogue cells as they move around the body.

This £400,000 microscope, one of only two in the world (the other one is at Harvard University in Cambridge, Massachusetts)  uses “vibrational” images to allow researchers to see deep into active cancer cells, giving a unique view of how the disease spreads.  Most cancer deaths are caused when diseased cells migrate within the body – a process called metastasis – and develop as secondary tumours. The new equipment will help researchers establish if a cancer has spread, and whether drugs might prevent this.

 Dr Alan Serrels who is a Cancer Research UK scientist is building the microscope with colleague Andy Downes from the School of Engineering at the University of Edinburgh.  Serrels said: “This microscope allows researchers to see what’s going on deep within living tissue. By spying on the inner workings of cells in this way, it will reveal clues as to how cancers grow and spread, as well as allowing scientists to directly witness the effects of treatments on tumours. The work will significantly improve our understanding of metastasis and reveal opportunities to develop new treatments to stop cancer in its tracks.”

It is hoped the technology will eventually lead to the development of new treatments to stop the disease spreading.

Click here to search our jobs in science!

Posted in Industry News, NewsTagged in , , , , , , , , ,

GSK to help to end 10 Neglected tropical diseases

GlaxoSmithKline (GSK) released a press statement this week announcing that it has joined other global pharmaceutical companies and leading organisations such as the World Health Organization (WHO), the Bill & Melinda Gates Foundation, the UK Department for International Development and the US Agency for International Development (USAID) in an effort to support developing countries to defeat neglected tropical diseases (NTDs). Neglected tropical diseases affect more than one billion people in developing countries, causing illness, disability and death, and increasing the burden on over-stretched health systems.

This united group will support the goals given this week by the WHO to control or eliminate ten of the 17 diseases designated as neglected tropical diseases by the end of the 2020. This includes eliminating five diseases: lymphatic filariasis (elephantiasis), guinea worm, blinding trachoma, sleeping sickness and leprosy, and controlling a further five: soil transmitted helminthes (intestinal worms), schistosomiasis, river blindness, Chagas and visceral leishmaniasis by 2020.

The CEO of GSK, Sir Andrew Witty said: “I am delighted to announce that GSK is part of this united effort to free future generations from the burden of neglected tropical diseases. We fully support the WHO’s bold vision and we are committed to playing our part in helping to achieve universal coverage of intervention programmes for diseases that can be controlled or eliminated by existing treatments, and to spur R&D into new treatments for diseases where none currently exist. Through this new partnership, we have both the means and the energy to strike a decisive blow against disease in the world’s poorest countries.”

Click here to search our jobs in Science now!

Posted in Industry News, News

Almac achieves success in their MHRA Audits

Pharmiweb has reported that Almac has achieved success in MHRA inspections at both their Craigavon Headquarters, Northern Ireland and Elvingston, Scotland sites. These inspections were the first biennial audits to confirm continued compliance with Investigation Medicinal Products (IMP) licenses and GMP certificates.

The first inspection audited Almac’s isotope laboratory facility in support of their IMP license. Following the MHRA’s acceptance of Almac’s response report, Almac’s licence will be applicable to both radiolabelled and non-labelled IMPs. The second inspection covered Almac’s analytical laboratory in Elvingston, Scotland, supporting its GMP certificate as a contract analytical facility.

The Inspector complimented the analytical team on their professionalism and laboratory high standards. As a result of this successful audit, two GMP certificates will be issued for human and veterinary applications.

President and Managing Director, Stephen Barr commented on the successful audits saying:
“We are delighted with the outcome of these inspections. It is reassuring to know that the value we place on our staff and facilities is recognised in this way, and adds further credibility to our wealth of experience and services we offer.”

Click here to search our current jobs in science now!

Posted in Industry News, NewsTagged in , , , , , , , , , ,

Anti-aging hope for Vitamin D

As reported by Pharmiweb,  current research suggests that Vitamin D supplements may have wide-ranging anti-ageing properties including the preservation of eyesight. The research is still at an early stage however research scientists believe it could have important implications for human health. Boosting the intake of vitamin D may have broad anti-ageing effects and in particular help prevent loss of vision and blindness in older people.

During the research study middle-aged mice treated with the vitamin for six weeks underwent changes in their eyes that led to improved vision. Levels of amyloid beta, a toxic protein linked to Alzheimer’s disease and known to be a hallmark of ageing, were also reduced in the animals’ eyes and blood vessels.

Lead scientist Professor Glen Jeffery, from the Institute of Ophthalmology at University College London, said: “Finding that amyloid deposits were reduced in the blood vessels of mice that had been given vitamin D supplements suggests that vitamin D could be useful in helping to prevent a range of age-related health problems, from deteriorating vision to heart disease.”

Click here to search our current jobs in science now!

Posted in Industry News, NewsTagged in , , , , , , , , , ,

GSK laboratory to help seek out Olympic drug cheats

As reported by London 2012, the pharmaceutical giant, GlaxoSmithKline have unveiled their Anti Doping Laboratory for the London 2012 Olympic Games.

The laboratory which is in Harlow, Essex will be operated by both scientists and leading experts from Kings College London. It will test 6, 250 samples throughout the duration of the Olympic and Paralympic Games, which is many more than have been tested in previous Games.

The new drug testing laboratory will employ over 1,000 staff to work within the anti-doping process, as well as 150 scientists who will carry out the testing. The team will be lead by Professor David Cowan from the Drug Control Centre at King’s College London. The laboratory will be in operation 24 hours a day, 7 days a week.

Sir Andrew Witty, CEO of GlaxoSmithKline, said: ‘As a science-based organisation, GSK is well placed to help deliver the scale and cutting edge technology required to run an operation like the anti-doping facility for London 2012.

‘We have worked with King’s to put systems in place to enable this laboratory to test more samples than any previous Games and at the same time developing a blueprint for doping operations at future Games.’

Click here to search our current jobs in science now.

Posted in Industry News, NewsTagged in , , , , , , , ,

North East scientists develop five a day fruit and veg test

As reported by The Journal Live, Scientists at the universities of Aberystwyth and Newcastle have developed a simple urine test to check whether or not patients are eating the recommended five portions of fruit and veg per day.

The prototype urine test can reveal what patients have been eating over the past week by identifying chemical fingerprints of substances that have been created by different foods. So far, chemical fingerprints have been found food fruit and veg such as raspberries, orange juice and broccoli.  The team of scientists believe that soon each food group will be identifiable and that a dip stick test will be available within the next five years.

Speaking of the test, Professor John Draper who lead the team of scientists at Aberystwyth university stated, “It should mean that for the first time researchers will be able to say for certain which items of food help protect against specific diseases, and those that can seriously increase the chance of getting a particular disease.”

Click here to search our science jobs in the North East now.

Posted in Industry News, NewsTagged in , , , , ,

UK scientists investigate the science of sprouts

As reported by The Telegraph, young scientists in the UK are investigating why it is that some people hate the taste of the Christmas dinner staple, the Brussels sprout.

Budding scientists at Cornwell’s Eden Project will be testing their DNA to find out whether or not they have a genetic variation of a certain gene which makes a chemical within Brussels sprouts taste particularly bitter.  Luckily for them, those who don’t have this mutation (it is thought that this is about half the world’s population) don’t taste the bitterness at all, meaning they can take full advantage of the nutritional goodness of the good old sprout.

This national programme is being run for the UK Association for Science and Discovery Centres (ADC) and is supported by the Wellcome Trust. The project aims to give young scientists some hands-on experience of working with DNA.

Talking of the programme, John Ellison, head of education strategy at Eden Project, said: “These workshops use Brussels sprouts and our own DNA to show how humans and plants have evolved together.

“The Eden Project provides the context to connect molecular biology with rainforest research into the plant diversity which is vital for future survival.”

Enjoy your sprouts and Merry Christmas!

Click here to search our jobs in science now.

Posted in Industry News, NewsTagged in , , , , , , ,

Oxford Research Scientists have revealed a potential new Malaria vaccine

As reported by BBC News Online, Research Scientists revealed a potential new malaria vaccine has shown promise in animal studies, according to research. An Oxford University team is to start safety trials in human volunteers after lab tests showed the vaccine works against all strains of the parasite.

UK scientists recently found the route malaria uses to enter blood cells. They hope to target this pathway in a new approach to developing a vaccine against malaria, which kills hundreds of thousands of people a year. Several potential malaria vaccines are already being tested in clinical trials; although no vaccine has yet been licensed for use.

One possibility is to exploit a recently-discovered potential weakness in the parasite’s life cycle. A team at the Sanger Institute found in November that a single receptor on the surface of red blood cells and a substance known as “PfRh5” on the parasite are crucial to the success of malaria in invading blood cells.

Early lab tests suggest a vaccine against the protein may prove effective, at least in animals. Dr Sandy Douglas is a Wellcome Trust Clinical Research Training Fellow from the University of Oxford told the BBC: “We have found a way of making antibodies that kill all different strains of malaria parasites. This is still early phase research in animals. The next step is to do clinical trials in people.”

If safety tests of the vaccine prove successful, clinical trials in patients could begin within the next two to three years, says the Oxford team.

Are you looking for a job in science? Click here to search for science jobs!

Posted in Industry News, NewsTagged in , , , , , , , , , , ,

£3.6m research project – effects of ageing

As reported by the Cambridge News, scientists in Cambridge are to take part in a £3.6m research project investigating the effects of ageing.

The project has received it’s funding from the Biotechnology and Biological Sciences Research Council (BBSRC). The scientists are from the Babraham Institute, Cambridge University and MRC Laboratory.

The study will aim to discover more about a mechanism that controls cells in our immune systems. Speaking of the study, Professor Douglas Kell, CEO of the Biotechnology and Biological Sciences Research Council stated,

“Maintaining and improving the health of older people so that they can live enjoyable and productive lives into their 80s and beyond is a major challenge facing society. Victories in public health and nutrition continue to increase life span around the world yet the lives of many older people are blighted by disability and disease. Combating the problems associated with old age will require an understanding at the most fundamental level of how our bodies change as we age. This team is well placed to deepen our understanding of how ageing affects our immune system and thus to provide knowledge that will be crucial for bioscience to help people live longer and healthier lives.”

Looking for a scientist job in Cambridge? Search our current science jobs now.

Posted in Industry News, NewsTagged in , , , , ,

Cambridge Biotech, play key role, €40m Collaboration

As reported by Cambune, companies from the Cambridge Biotech cluster will play a key role in an innovative epigenetics collaboration called Blueprint.

This €40m project which will aim to discover how the epigenome influences health and disease. It is hoped that this will help lead to great advances in the treatment of a variety of human diseases.

Cambridge-based  contributors that will be involved with Blueprint, include:

The study of epigenetics can help explain how human genes are influenced by external forces. The genome is essentially the body’s building blocks, so it is the epigenome that determines how these building blocks construct living things.

When the regulation of this is faulty, it can result in diseases such as cancer, diabetes, obesity  and cardiovascular disease.

Professor Wolf Reik, associate director at the Babraham Institute and Professor of Epigenetics at the University of Cambridge, explains:

“It is clear that our susceptibility to disease can only be partially explained by genes alone and epigenetics is emerging as an important research area that is bringing insight to many adult conditions like heart disease, diabetes, cancer and autoimmune disorders.

“The purpose of project Blueprint is to determine the properties and functions of epigenomes in development and disease.”

Are you looking for a job in the Biotechnology Industry? Click here to search our current Biotech jobs now.

Posted in Industry News, NewsTagged in , , , , , ,

Sirius Minerals to Create 1,000 Jobs in Yorkshire

Sirius Minerals has recently completed its first successful exploratory borehole at the York Potash project, and has received a grant from the UK government, reports proactiveinvestors.co.uk.

The £2.8 million grant is in response to the very strong possibility of the polyhalite grade that is being drilled for has been found in the main beds is of particularly high grade in the range presented in the York exploratory targets. The grant, which was given the day after the discoveries is intended to help the regional development of the area.

The Yorkshire based project is expected to create 1,000 direct jobs and over 4,000 indirect jobs, as well as supplying the UK with a long-term source of potash, which is used in the agricultural industry. The discovery and government aid has also seen Sirius Mineral’s share prices double in a month.

Looking for a job in the science industry? Start by clicking here, now

Posted in Industry News, Jobs, Mobile News, NewsTagged in , , , , , , , , , , , , , , , , ,

GSK plans to build UK factory and create 1,000 jobs

As reported in This is Money.co.uk, the pharmaceutical company GlaxoSmithKline (GSK) is planning on building it’s first new UK factory in 30 years. This will create 1,000 jobs.

As Andrew Witty, CEO of GSK explains, the plan comes are a result of tax breaks on innovation introduced by Chancellor George Osbourne,  ‘Because of changes in the UK tax regime, it will be our intention to bring more activity to Britain and take advantage of the situation here and increase our contribution to Britain. If it [corporation tax] is going to come down over the next few years, it will attract us to pay more tax here.’

The global pharma are considering Cumbria, County Durham and two locations in Scotland for their new factory. A decision is expected to be made in May.

Looking for a new position in the Pharmaceutical Industry? Click here to search our current pharmaceutical jobs now.

Posted in Industry News, NewsTagged in , , , , , , , , , , ,

20% of UK Workforce has a Science Job

The Financial Times has reported that approximately one fifth of the UK workforce has a science based job.

5.8 million people are scientists or use science skills daily, the Science Council has discovered in a recent study. The number includes ‘secondary science workers’ such as nurses or software engineers. Scientists were found to be in industries as diverse as education, finance and farming, as well as more traditional scientific sectors, such as the chemical industry.

Chief executive of the Science Council, Diana Garnham, has said that secondary science roles can be “found literally everywhere in the economy.” The research indicates that by 2030, there could be over 7 million people involved in science in some way, prompting Diana Garnham to say “the research begins to explain… why there is such huge demand for people with science qualifications.”

Looking for a job in the science industry? Start by clicking here, now

Posted in Industry News, Mobile News, NewsTagged in , , , , , , , , , , , , , , , , , , , , ,

Teesside's Renewable Energy Renaissance

The Financial Times has reported that Teesside is becoming a hotbed for renewable energy investment, with around thirty low carbon investments.

These investments are set to be added to, with various proposals set to be implemented. They range from an anaerobic energy research plant to a processing plant for over 400,000 tonnes of household waste to a £200 million advanced gasification plant for the new energy and technology plant near Billingham. These will all create jobs and investment.

Another proposed scheme is the Tenergis project, which will process crude oil and produce diesel, kerosene and hydrogen. The North East of England Process Industry Cluster (NEPIC) estimates over 50 million metric tonnes of waste is produced annually, with over three quarters being recyclable. NEPIC believes the government should review its policies on industry and energy to protect the UK’s industrial base from carbon taxation. The hesitancy has left projects such as a £500 million biomass plant on hold in the area.

Looking for a job in the science industry? Start by clicking here, now

Posted in Industry News, Mobile News, NewsTagged in , , , , , , , , , , , , , , , ,